These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 17700290)

  • 1. Glaucoma in the United States and europe: predicting costs and surgical rates based upon stage of disease.
    Lee PP; Kelly SP; Mills RP; Traverso CE; Walt JG; Doyle JJ; Katz LM; Siegartel LR;
    J Glaucoma; 2007 Aug; 16(5):471-8. PubMed ID: 17700290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observational two-year chart review of newly diagnosed patients in Sweden and the United States.
    Kobelt-Nguyen G; Gerdtham UG; Alm A
    J Glaucoma; 1998 Apr; 7(2):95-104. PubMed ID: 9559495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs and utilization of end-stage glaucoma patients receiving visual rehabilitation care: a US multisite retrospective study.
    Gieser DK; Tracy Williams R; O'Connell W; Pasquale LR; Rosenthal BP; Walt JG; Katz LM; Siegartel LR; Wang L; Rosenblatt LC; Stern LS; Doyle JJ
    J Glaucoma; 2006 Oct; 15(5):419-25. PubMed ID: 16988605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
    Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of mean deviation scores and resource utilization among patients with glaucoma: a retrospective United States and European chart review analysis.
    Berenson K; Kymes S; Walt JG; Siegartel LR
    J Glaucoma; 2009; 18(5):390-4. PubMed ID: 19525730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma.
    Lee PP; Walt JG; Doyle JJ; Kotak SV; Evans SJ; Budenz DL; Chen PP; Coleman AL; Feldman RM; Jampel HD; Katz LJ; Mills RP; Myers JS; Noecker RJ; Piltz-Seymour JR; Ritch RR; Schacknow PN; Serle JB; Trick GL
    Arch Ophthalmol; 2006 Jan; 124(1):12-9. PubMed ID: 16401779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between intraocular pressure variation and glaucoma progression: data from a United States chart review.
    Lee PP; Walt JW; Rosenblatt LC; Siegartel LR; Stern LS;
    Am J Ophthalmol; 2007 Dec; 144(6):901-907. PubMed ID: 17919446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden.
    Lindblom B; Nordmann JP; Sellem E; Chen E; Gold R; Polland W; Williamson W; Buchholz P; Walt JG; Groleau D; Curry A; Evans SJ
    Acta Ophthalmol Scand; 2006 Feb; 84(1):74-83. PubMed ID: 16445443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between mean intraocular pressure, disease stability and cost of treating glaucoma in Canada.
    Vicente C; Walker J; Buys Y; Einarson TR; Covert D; Iskedjian M
    Curr Med Res Opin; 2004 Aug; 20(8):1245-51. PubMed ID: 15324527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of resource utilization in the treatment of open-angle glaucoma between two cities in Finland: is more better?
    Hagman J
    Acta Ophthalmol; 2013 May; 91 Thesis 3():1-47. PubMed ID: 23621767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressive symptomatology, medication persistence, and associated healthcare costs in older adults with glaucoma.
    Jayawant SS; Bhosle MJ; Anderson RT; Balkrishnan R
    J Glaucoma; 2007 Sep; 16(6):513-20. PubMed ID: 17873711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An observational, retrospective two-year cost study in primary open-angle glaucoma and ocular hypertension in newly diagnosed patients].
    Rouland JF; Peigne G; Sellem E; Renard JP; Williamson W; Filippi JM; Cohn H; Hamard P; Abellan P; Chagnon A; Malet F; Haye I
    J Fr Ophtalmol; 2001 Mar; 24(3):233-43. PubMed ID: 11285438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glaucoma care cost-effectiveness.
    Hoskins HD
    Ophthalmology; 2009 May; 116(5):1016. PubMed ID: 19410965
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictors of long-term progression in the early manifest glaucoma trial.
    Leske MC; Heijl A; Hyman L; Bengtsson B; Dong L; Yang Z;
    Ophthalmology; 2007 Nov; 114(11):1965-72. PubMed ID: 17628686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe.
    Traverso CE; Walt JG; Kelly SP; Hommer AH; Bron AM; Denis P; Nordmann JP; Renard JP; Bayer A; Grehn F; Pfeiffer N; Cedrone C; Gandolfi S; Orzalesi N; Nucci C; Rossetti L; Azuara-Blanco A; Bagnis A; Hitchings R; Salmon JF; Bricola G; Buchholz PM; Kotak SV; Katz LM; Siegartel LR; Doyle JJ
    Br J Ophthalmol; 2005 Oct; 89(10):1245-9. PubMed ID: 16170109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The increased cost of medical services for people diagnosed with primary open-angle glaucoma: a decision analytic approach.
    Kymes SM; Plotzke MR; Li JZ; Nichol MB; Wu J; Fain J
    Am J Ophthalmol; 2010 Jul; 150(1):74-81. PubMed ID: 20493465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct cost and predictive factors for treatment in patients with ocular hypertension or early, moderate and advanced primary open-angle glaucoma: the CoGIS study in Germany.
    Lorenz K; Wolfram C; Breitscheidel L; Shlaen M; Verboven Y; Pfeiffer N
    Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):2019-28. PubMed ID: 23624617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between corneal thickness, mean intraocular pressure, disease stability and severity, and cost of treatment in glaucoma: a Canadian analysis.
    Walker JH; Buys Y; Trope G; Vicente C; Einarson TR; Covert D; Iskedjian M
    Curr Med Res Opin; 2005 Apr; 21(4):489-94. PubMed ID: 15899096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Medicare costs of endophthalmitis among patients after cataract surgery.
    Schmier JK; Halpern MT; Covert DW; Lau EC; Robin AL
    Ophthalmology; 2007 Jun; 114(6):1094-9. PubMed ID: 17320963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.